Ingersoll Rand Drives Margin Expansion Through Synergies and Productivity Initiatives
We think Ingersoll Rand is on solid financial footing. The company ended 2024 with a net leverage ratio of around 1.6 times adjusted EBITDA, and debt maturities are well spread out. At the time of the ...
West Pharmaceutical's Long-Term Growth Intact, but Margin Expansion Less Uncertain
West Pharma’s financial strength is solid, and the firm has historically managed a very strong balance sheet. As of year-end 2023, West had total debt outstanding of $206 million. West has ...